The fragility of landmark randomised controlled trials in glaucoma: A systematic review
Objective: Randomized controlled trials (RCTs) form the cornerstone of evidence-based glaucoma care. However, the robustness of statistically significant results in these trials is often unclear. The fragility index (FI) quantifies how easy it is to reverse a significant result, while the fragility [for full text, please go to the a.m. URL]
Authors
- Sana Hamid
- Amar Hamdan
- Di Zou (ORCID: https://orcid.org/0000-0003-3408-9499)
- Jeremy Tan
- Minsu Jung
- Peng Khaw
- Abdus Samad Ansari
Institutions
- Moorfields Eye Hospital NHS Foundation Trust (GB)
- Universität Hamburg (DE)
- Sydney Hospital (AU)
- UNSW Sydney (AU)
- University Medical Center Hamburg-Eppendorf (DE)
- Moorfields Eye Hospital (GB)
- University College London (GB)
Publication Details
- Journal
- German Medical Science (German Research Foundation)
- Published
- 2026-06-17
- DOI
- https://doi.org/10.3205/26doc001
- Primary Topic
- Glaucoma and retinal disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00